New Enterprise Associates 16, L.P.'s Form 4 filing
NeueHealth, Inc. (NEUE) · filed Oct 6, 2025
- Accession no.
- 0001193125-25-232130
- Filed
- Oct 6, 2025, 5:48 PM ET
- Trade date
- Oct 2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.89K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| New Enterprise Associates 16, L.P.CIK 0001694560 | Director, 10% Owner |
| NEA Partners 16, L.P.CIK 0001712881 | Director, 10% Owner |
| Nea 16 GP, LLCCIK 0001712882 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Common Stock | XIn-the-money exerciseAcquired | +189,195 | $0.01 | +$1,891.95 | 788,259 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −280 | $6.75 | −$1,890 | 787,979 | Direct | |
| Oct 2, 2025 | Common Stock | MOption exerciseAcquired | +372,255 | $0.01 | +$3,722.55 | 1,160,234 | Direct | |
| Oct 2, 2025 | Common Stock | FTax withholdingDisposed | −551 | $6.75 | −$3,719.25 | 1,159,683 | Direct | |
| Oct 2, 2025 | Common Stock | DReturned to the companyDisposed | −1,159,683 | –F3 | – | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Common Stock | XIn-the-money exerciseDisposed | −189,195 | $0.00 | $0 | 0 | Direct | Duplicate filing |
| Oct 2, 2025 | Common Stock | AGrant or awardAcquired | +372,255 | –F5 | – | 372,255 | Direct | |
| Oct 2, 2025 | Common Stock | MOption exerciseDisposed | −372,255 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Pursuant to the Agreement and Plan of Merger, dated as of December 23, 2024, by and among the Issuer, NH Holdings 2025, Inc. ("Parent") and NH Holdings Acquisition 2025, Inc. ("Merger Sub"), on October 2, 2025, Merger Sub merged with and into the Issuer with the Issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to rollover agreements entered into between certain of the Reporting Persons and NH Holdings 2025 SPV, L.P. ("Ultimate Parent"), Parent and Merger Sub, each share of the Issuer's Common Stock beneficially owned by the Reporting Persons was contributed to Ultimate Parent in exchange for limited partnership interests in Ultimate Parent. Each such share of the Issuer's Common Stock was then cancelled and ceased to exist.
Referenced by the price of 1 transaction in Table I.
- F5
Warrants issued pursuant to the Warrantholders Agreement, dated September 30, 2025 between the Issuer and the holders listed on Schedule 1 thereto, and the Credit Agreement, dated August 4, 2023, as amended by that certain Incremental Amendment No. 1, dated as of October 2, 2023, that certain Incremental Amendment No. 2, dated as of April 8, 2024, that certain Amendment No. 3, dated as of June 21, 2024, that certain Amendment No. 4, dated as of October 29, 2024, and that certain Amendment No. 5, dated as of September 30, 2025, between the Issuer and the lenders thereto.
Referenced by the price of 1 transaction in Table II.